A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department of Health and Human Services begins a “coordinated wind-down” of research studying mRNA vaccine technology.

The grants, which were being developed under the Biomedical Advanced Research and Development Authority, amounted to nearly $500 million in funding to research projects. According to the agency website, researchers at Emory received $750,000 to develop an inhalable dry powder that could be used to immunize patients against influenza and SARS-CoV-2, the virus that causes COVID-19. Emory University did not respond to a request for comment.

Vaccines using mRNA were first developed by Pfizer-BioNTech and Moderna in response to the COVID-19 pandemic, and won a Nobe

See Full Page